Physicochemical Properties
| Molecular Formula | C27H24F6N4O4S |
| Molecular Weight | 614.559286117554 |
| Exact Mass | 614.142 |
| CAS # | 1252637-46-9 |
| PubChem CID | 59543651 |
| Appearance | White to off-white solid powder |
| LogP | 3.6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 6 |
| Heavy Atom Count | 42 |
| Complexity | 1250 |
| Defined Atom Stereocenter Count | 2 |
| SMILES | CC1=NC=CC(=C1)C2=CC(=C(C=C2)S(=O)(=O)[C@@H]3C[C@H](N(C3)C(=O)C4(CC4)C(F)(F)F)C(=O)NC5(CC5)C#N)C(F)(F)F |
| InChi Key | CDBYZSRUFZXRLK-QUCCMNQESA-N |
| InChi Code | InChI=1S/C27H24F6N4O4S/c1-15-10-17(4-9-35-15)16-2-3-21(19(11-16)26(28,29)30)42(40,41)18-12-20(22(38)36-24(14-34)5-6-24)37(13-18)23(39)25(7-8-25)27(31,32)33/h2-4,9-11,18,20H,5-8,12-13H2,1H3,(H,36,38)/t18-,20+/m1/s1 |
| Chemical Name | (2S,4R)-N-(1-cyanocyclopropyl)-4-[4-(2-methylpyridin-4-yl)-2-(trifluoromethyl)phenyl]sulfonyl-1-[1-(trifluoromethyl)cyclopropanecarbonyl]pyrrolidine-2-carboxamide |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture and light. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | human Cathepsin S 0.4 nM (IC50) murine Cathepsin S 0.5 nM (IC50) |
| ln Vitro | In mouse (A20) or human (RAJI) cell lines, RO5461111 (16 h) is cytoactive and dramatically lowers splenic dendritic cell activation, as well as the subsequent growth and activation of CD4 T cells and CD4/CD8 double negative T cells[1]. |
| ln Vivo | Following sheep IgG immunization, RO5461111 (0.1–100 mg/kg; oral; single dosage) prevents T cell priming and anti-sheep IgG in BALB/c mice[1]. In MRL-Fas(lpr) mice, RO5461111 (1.31 mg/mouse or 30 mg/kg; oral; 8 weeks) decreases hypergammaglobulinemia, lupus autoantibody product F, and disturbs the germinal center (e.g., diminishes CXCL12 expression). Moreover, RO5461111 can lessen lupus nephritis and lessen lung inflammation[1]. |
| Animal Protocol |
Animal/Disease Models: Female MRL-Fas(lpr) mice (12weeks old; with proteinuria/serum creatinine levels up)[1] Doses: 262.5 mg/kg chow; or 5 mg/mouse with 1.31 mg/mouse Route of Administration: Oral gavage; 8 weeks Experimental Results: decreased the activation and expansion of spleen dendritic cells, CD4, double-negative T cells and plasma cells. decreased plasma levels of IL-10 and TNF-α. |
| References |
[1]. Cathepsin S inhibition suppresses systemic lupus erythematosus and lupus nephritis because cathepsin S is essential for MHC class II-mediated CD4 T cell and B cell priming. Ann Rheum Dis. 2015 Feb;74(2):452-63. [2]. Preparation of proline dipeptidyl nitrile derivatives as cathepsin, particularly cathepsin S and L, inhibitors: United States, US20100267722. 2010-10-21. |
Solubility Data
| Solubility (In Vitro) | DMSO: 100 mg/mL (162.72 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 1.67 mg/mL (2.72 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 16.7 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 1.67 mg/mL (2.72 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 16.7 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.6272 mL | 8.1359 mL | 16.2718 mL | |
| 5 mM | 0.3254 mL | 1.6272 mL | 3.2544 mL | |
| 10 mM | 0.1627 mL | 0.8136 mL | 1.6272 mL |